1233 ET - Doximity should see engagement ramping for the foreseeable future, providing a durable revenue growth driver over time, Raymond James analysts say in a note after meeting with the company's CEO. The company offers a much more compelling suite of AI productivity tools than its competitors, which largely offer point solutions, and also said recently it will offer peer review functionality to its clinical decision-making tools, the analysts say. Those offerings should drive further adoption of the company's products, they say. "We believe AI will provide a material increase in engagement for Doximity, where we believe the company has an underappreciated competitive moat," they say, backing their strong buy rating on the stock. (kelly.cloonan@wsj.com)
(END) Dow Jones Newswires
December 29, 2025 12:33 ET (17:33 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Comments